Pros and Cons of Dynavax Technologies Corp in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
B****
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Dynavax Technologies Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Dynavax Technologies Corp | - | - | - | - | - | - | - |
| Heron Therapeutics Inc. | 4.690% | 16.638% | 41.470% | -49.754% | -8.438% | -52.778% | -92.985% |
| Evolus Inc | 2.510% | -6.031% | 23.198% | -57.192% | -22.239% | -41.945% | -42.340% |
| Sangamo Therapeutics Inc. | -10.030% | -53.171% | -61.677% | -85.041% | -70.869% | -92.335% | -98.960% |
Comments
Dynavax Technologies (NASDAQ:DVAX) was upgraded by analysts at Wall Street Zen to a "strong-buy" rating.
Show more
Ratings data for DVAX provided by MarketBeat
Dynavax Technologies (NASDAQ:DVAX) was upgraded by analysts at Wall Street Zen from a "buy" rating to a "strong-buy" rating.
Show more
Ratings data for DVAX provided by MarketBeat
Dynavax Technologies Co. (NASDAQ: DVAX) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $12.00 to $10.00. They now have a "sell" rating on the stock.
Show more
Ratings data for DVAX provided by MarketBeat
News
Dynavax President and COO Sells 114,000 Shares on Sanofi Acquisition News
David Novack, President & COO of Dynavax Technologies Corporation (NASDAQ:DVAX), exercised 114,000 stock options and immediately sold the resulting shares for a transaction value of approximately
Why Dynavax Stock Soared Today
Shares of Dynavax Technologies (NASDAQ: DVAX) popped on Wednesday after the vaccine maker struck a deal to be acquired by Sanofi (NASDAQ: SNY).
As of 3:00 p.m. EST, Dynavax's stock price was up